order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Location
Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
Telephone Numbers
Customer Service: (800) 227-6666 / (650) 697-3600
Contact Us
Additional Contact Details
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
order histories, retained contact details for faster checkout, review submissions, and special promotions.
CCR9 / CD199
chemokine (C-C motif) receptor 9
CCR9 is a member of the beta chemokine receptor family. It is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. Chemokines and their receptors are key regulators of the thymocytes migration and maturation in normal and inflammation conditions. The specific ligand of this receptor is CCL25. It has been found that this gene is differentially expressed by T lymphocytes of small intestine and colon, suggested a role in the thymocytes recruitment and development that may permit functional specialization of immune responses in different segment of the gastrointestinal tract. This gene is mapped to the chemokine receptor gene cluster region. Two alternatively spliced transcript variants have been described. Multiple transcript variants encoding different isoforms have been found for this gene.
| Gene Name: | chemokine (C-C motif) receptor 9 |
| Family/Subfamily: | GPCR , Chemokine |
| Synonyms: | CCR9, C-C CKR-9, CC-CKR-9, CCR-9, CDw199 antigen, C-C chemokine receptor 9, C-C chemokine receptor type 9, Chemokine c-c motif receptor 9, CDw199, G protein-coupled receptor 28, GPR-9-6, G-protein coupled receptor 28, GPR28, CD199 |
| Target Sequences: | NM_006641 NP_006632.2 P51686 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.
